Journal of Molecular and Cellular Cardiology
Volume 49, Issue 2 , Pages 271-279 , August 2010

Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion

  • Víctor Hernando

      Affiliations

    • Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    • ,
  • Javier Inserte

      Affiliations

    • Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Servicio de Cardiologia, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron, 119-129, 08035 Barcelona, Spain. Tel.: +34 93 4894038; fax: +34 93 4894032.
    • ,
  • Carmem Luíza Sartório

      Affiliations

    • Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    • ,
  • Víctor M. Parra

      Affiliations

    • Facultad de Medicina, Universidad de Chile, Santiago, Chile
    • ,
  • Marcos Poncelas-Nozal

      Affiliations

    • Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    • ,
  • David Garcia-Dorado

      Affiliations

    • Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Received 24 December 2009 ,Revised 9 February 2010 ,Accepted 28 February 2010.

References 

  1. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998;38(2):291–300
  2. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res. 2004;61(3):372–385
  3. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Agullo L, Pina P, Soler-Soler J. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res. 2004;64(1):105–114
  4. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83(3):731–801
  5. Inserte J, Garcia-Dorado D, Hernando V, Soler-Soler J. Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res. 2005;97(5):465–473
  6. Singh RB, Chohan PK, Dhalla NS, Netticadan T. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J Mol Cell Cardiol. 2004;37(1):101–110
  7. Papp Z, van der Velden J, Stienen GJ. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart. Cardiovasc Res. 2000;45(4):981–993
  8. Neuhof C, Fabiunk V, Speth M, Moller A, Fritz F, Tillmanns H, et al. Reduction of myocardial infarction by postischemic administration of the calpain inhibitor A-705253 in comparison to the Na(+)/H(+) exchange inhibitor Cariporide in isolated perfused rabbit hearts. Biol Chem. 2008;389(12):1505–1512
  9. Khalil PN, Neuhof C, Huss R, Pollhammer M, Khalil MN, Neuhof H, et al. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. Eur J Pharmacol. 2005;528(1–3):124–131
  10. Molinari M, Carafoli E. Calpain: a cytosolic proteinase active at the membranes. J Membr Biol. 1997;156(1):1–8
  11. Zhao X, Newcomb JK, Posmantur RM, Wang KK, Pike BR, Hayes RL. pH dependency of mu-calpain and m-calpain activity assayed by casein zymography following traumatic brain injury in the rat. Neurosci Lett. 1998;247(1):53–57
  12. Kendall TL, Koohmaraie M, Arbona JR, Williams SE, Young LL. Effect of pH and ionic strength on bovine m-calpain and calpastatin activity. J Anim Sci. 1993;71(1):96–104
  13. Liu X, Van Vleet T, Schnellmann RG. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol. 2004;44:349–370
  14. Inserte J, Barba I, Hernando V, Garcia-Dorado D. Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res. 2009;81(1):116–122
  15. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Padilla F, Barrabes JA, Pina P, et al. Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res. 2002;55(4):739–748
  16. Garcia-Dorado D, Theroux P, Duran JM, Solares J, Alonso J, Sanz E, et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition and infarct geometry during coronary artery occlusion and reperfusion. Circulation. 1992;85:1160–1174
  17. Das M, Gherghiceanu M, Lekli I, Mukherjee S, Popescu LM, Das DK. Essential role of lipid raft in ischemic preconditioning. Cell Physiol Biochem. 2008;21(4):325–334
  18. Donkor IO. A survey of calpain inhibitors. Curr Med Chem. 2000;7(12):1171–1188
  19. Nuzzi PA, Senetar MA, Huttenlocher A. Asymmetric localization of calpain 2 during neutrophil chemotaxis. Mol Biol Cell. 2007;18(3):795–805
  20. Melloni E, Averna M, Stifanese R, De Tullio R, Defranchi E, Salamino F, et al. Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?. J Biol Chem. 2006;281(34):24945–24954
  21. Hood JL, Brooks WH, Roszman TL. Subcellular mobility of the calpain/calpastatin network: an organelle transient. Bioessays. 2006;28(8):850–859
  22. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res. 2004;61(3):365–371
  23. Allshire A, Piper HM, Cuthbertson KS, Cobbold PH. Cytosolic free Ca2+ in single rat heart cells during anoxia and reoxygenation. Biochem J. 1987;244(2):381–385
  24. Kingsley PB, Sako EY, Yang MQ, Zimmer SD, Ugurbil K, Foker JE, et al. Ischemic contracture begins when anaerobic glycolysis stops: a 31P-NMR study of isolated rat hearts. Am J Physiol. 1991;261(2 Pt 2):H469–H478
  25. Liu X, Rainey JJ, Harriman JF, Schnellmann RG. Calpains mediate acute renal cell death: role of autolysis and translocation. Am J Physiol Renal Physiol. 2001;281(4):F728–F738
  26. Ostwald K, Hayashi M, Nakamura M, Kawashima S. Subcellular distribution of calpain and calpastatin immunoreactivity and fodrin proteolysis in rabbit hippocampus after hypoxia and glucocorticoid treatment. J Neurochem. 1994;63(3):1069–1076
  27. Morford LA, Forrest K, Logan B, Overstreet LK, Goebel J, Brooks WH, et al. Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells. Biochem Biophys Res Commun. 2002;295(2):540–546
  28. Goudenege S, Poussard S, Dulong S, Cottin P. Biologically active milli-calpain associated with caveolae is involved in a spatially compartmentalised signalling involving protein kinase C alpha and myristoylated alanine-rich C-kinase substrate (MARCKS). Int J Biochem Cell Biol. 2005;37(9):1900–1910
  29. Spencer MJ, Tidball JG. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res. 1996;226(2):264–272
  30. Larsen TH, Dalen H, Sommer JR, Boyle R, Lieberman M. Membrane skeleton in cultured chick cardiac myocytes revealed by high resolution immunocytochemistry. Histochem Cell Biol. 1999;112(4):307–316
  31. Jordan C, Puschel B, Koob R, Drenckhahn D. Identification of a binding motif for ankyrin on the alpha-subunit of Na+, K(+)-ATPase. J Biol Chem. 1995;270(50):29971–29975
  32. Rubtsov AM, Lopina OD. Ankyrins. FEBS Lett. 2000;482(1–2):1–5
  33. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem. 2001;276(33):30724–30728
  34. Markgraf CG, Velayo NL, Johnson MP, McCarty DR, Medhi S, Koehl JR, et al. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke. 1998;29(1):152–158

PII: S0022-2828(10)00085-4

doi: 10.1016/j.yjmcc.2010.02.024

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 2 , Pages 271-279 , August 2010

Article Tools

* Image Usage & Resolution